Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hector de la Mora-Molina"'
Autor:
Rafael Reyes Arciniega, Hector De la Mora Molina, Yanin Chavarri Guerra, Jose Luis Rodriguez Olivares, Enrique Soto Perez De Celis, Arantxa Lagunas Salazar, Osvaldo M Mutchinick, Jazmin Arteaga Vazquez, Andrea de la O Murillo, Rosa Elena Caballero Landinez
Publikováno v:
Cancer Research. 80:P1-15
Background: Breast cancer incidence is increasing globally, and a significant proportion of the disease has been linked to genetic susceptibility. Genetic knowledge and skills are essential for achieving optimal cancer care and prevention. However, i
Autor:
Cesar Ramos-Remus, Lilia Patricia Bustamante-Montes, Hector de la Mora-Molina, Edgar A. Castañeda-Barragan, Martha Navarrete-Lorenzon, Jose Dionisio Castillo-Ortiz, Francisco Javier Aceves-Avila, Jose Yañez, Leon Sandoval-Garcia, Aldo Barajas-Ochoa
Publikováno v:
Seminars in Arthritis and Rheumatism. 48:547-552
Objective To assess trends in the length and readability of informed consent forms (ICFs) for industry-sponsored multinational clinical trials (RCTs) in rheumatology over a 17-year period. Additionally, to assess the health literacy (HL) and percepti
Autor:
Jose Luis Rodriguez Olivares, Yanin Chavarri Guerra, Jazmin Arteaga, Hector De la Mora Molina, Enrique Soto Perez De Celis, Fernando Candanedo Gonzalez, Pamela Rivero García, Danielle Castillo, Jeffrey N. Weitzel
Publikováno v:
Journal of Clinical Oncology. 40:69-69
69 Background: Lynch syndrome (LS) is the most frequent hereditary cancer syndrome among patients with colorectal cancer. Screening tests such as immunohistochemistry (IHC) for mismatch repair (MMR) proteins and PREMM5 model help to identify patients
Autor:
Jose Luis Rodriguez Olivares, Yanin Chavarri Guerra, Jazmin Arteaga, Hector De la Mora Molina, Andrés Rodríguez-Faure, Ana María Hernández, Danielle Castillo, Jeffrey N. Weitzel
Publikováno v:
Journal of Clinical Oncology. 40:540-540
540 Background: The reported frequency of germline pathogenic variants (PVs) in patients with pancreatic cancer is 8-10%. Depending on the setting, pancreatic cancer-associated germline PVs in the BRCA and CDKN2A genes are the most commonly detected.
Autor:
Luis Aguilar-Lozano, Cesar Omar Vargas-Serafin, Carlos Sandoval-Castro, Cesar Ramos-Remus, Jose Dionisio Castillo-Ortiz, Adriana Sanchez-Ortiz, Francisco Javier Aceves-Avila, Ariadna Ramos-Gomez, Hilario Avila-Armengol, Hector de la Mora-Molina, Jorge Padilla-Ibarra
Publikováno v:
Arthritis & Rheumatology. 67:2837-2844
Objective Although blood bank-based studies have shown that rheumatoid arthritis (RA)-related autoantibodies are present before the onset of RA, information on their positive predictive value (PPV) for development of RA in healthy individuals is scar
Autor:
Cesar Ramos-Remus, Andrea Ramirez-Gomez, Jose Dionisio Castillo-Ortiz, Cesar Omar Vargas-Serafin, Francisco Javier Aceves-Avila, Hector de la Mora-Molina, Paul Davis, Mireya Elizabeth Gonzalez-Leija, Raul Pacheco-Lorenzo, Anthony S. Russell
Publikováno v:
Clinical Rheumatology. 33:561-566
This study aims to explore the different connotations and potential offensiveness of ten mechanistic labels in newly referred Mexican patients with rheumatic symptoms as well as in Mexican and Canadian rheumatologists. Patients with musculoskeletal c
Autor:
Cesar, Ramos-Remus, Jose Dionisio, Castillo-Ortiz, Luis, Aguilar-Lozano, Jorge, Padilla-Ibarra, Carlos, Sandoval-Castro, Cesar Omar, Vargas-Serafin, Hector, de la Mora-Molina, Ariadna, Ramos-Gomez, Adriana, Sanchez-Ortiz, Hilario, Avila-Armengol, Francisco Javier, Aceves-Avila
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 67(11)
Although blood bank-based studies have shown that rheumatoid arthritis (RA)-related autoantibodies are present before the onset of RA, information on their positive predictive value (PPV) for development of RA in healthy individuals is scarce. This s